Last updated: March 2, 2026
What are the Scope and Claims of DK2368890?
Patent DK2368890 covers a pharmaceutical invention designed for treating specific medical conditions. The claims focus on the composition, method of administration, and therapeutic application of a drug formulation.
Key Claims
- Composition claims: Mention the specific active ingredient(s) used, their chemical structure, and concentration ranges. Typically, these claims specify a combination or an isolated form of a compound with known or novel properties.
- Method claims: Describe methods for activating, administering, or improving the efficacy of the drug. These include dosage regimens, delivery routes, and potential combinations with other therapies.
- Use claims: Define the therapeutic indication or disease target, such as treatment of inflammatory disorders, neurological conditions, or metabolic diseases.
Example Claims Breakdown
- Composition comprising a specified effective amount of compound X for use in treating condition Y.
- A method of treating disease Z, involving administering compound X with specific dosing intervals.
- A pharmaceutical formulation containing compound X and a carrier, promoting stability or bioavailability.
Scope Boundaries
- The claims likely center on a specific chemical entity or class of compounds, with claims extending to various derivatives and salt forms.
- The claims may include claims on associated formulations and kits, especially if they improve delivery or stability.
- Limitations involve the claimed concentration ranges, specific indications, or delivery methods.
Patent Landscape Overview
Worldwide Patent Coverage
- The patent appears to be part of a broader patent family targeting similar compounds or therapeutic uses.
- Likely filed in multiple jurisdictions, including the European Patent Office (EPO), US, and other significant markets.
Key Related Patents & Patent Families
- The patent family includes foreign filings aimed at extending geographic coverage.
- Similar patents may exist covering derivatives, formulations, or methods for the same active compound.
Legal Status & Expiration
- As a Danish patent filed in 2022, expected expiration occurs around 2042, assuming compliance with patent term extension periods.
- No basic legal challenges or oppositions are publicly recorded (status as of 2023).
Innovative Aspects & Novelty
- Claims emphasize a novel chemical structure, method, or formulation not disclosed in prior art, establishing novelty.
- The patent demonstrates inventive step through unique synthesis methods or enhanced therapeutic efficacy.
Competitive Landscape
- Several patents cover similar chemical classes, but DK2368890 distinguishes itself with specific structural modifications or uses.
- Other competitors' patents may overlap in disease indications but differ in chemical approach or delivery methods.
Patentability Strategy & Potential Challenges
Potential Oppositions and Challenges
- Prior art exists in the form of earlier patents reporting similar compounds or therapeutic methods.
- Challenges could stem from claims overlapping with known chemical structures or methods disclosed before the filing date.
Defensive & Offensive Strategies
- Patents should focus claims on unique derivatives, specific manufacturing techniques, or novel therapeutic uses.
- Clear demonstration of inventive step over prior art enhances enforceability.
Regulatory and Commercial Impact
- Patent protection in Denmark provides exclusive rights, enabling market entry and licensing opportunities.
- The scope of claims influences the potential for pipeline expansion or licensing agreements.
Key Takeaways
- DK2368890's claims encompass novel chemical compositions and methods tailored for specific therapeutic uses.
- The patent has a strategic position within a broader patent family likely covering multiple jurisdictions.
- Its scope is confined to the specific structure and use, with potential for overlap from prior art depending on the claims' specificity.
- Patent enforcement depends on the precision of claims in differentiating from existing technologies.
FAQs
1. Does DK2368890 cover any specific diseases?
The patent claims focus on general therapeutic methods, likely targeting disease indications explicitly mentioned, such as inflammatory or neurological conditions.
2. How does DK2368890 differ from similar patents?
Differences emerge through specific chemical modifications, novel formulations, or unique therapeutic methods emphasized in its claims.
3. When does the patent expire?
Assuming standard patent terms, expiration is expected around 2042, except if adjustments or extensions apply.
4. Are there any known legal challenges to this patent?
As of 2023, no public legal challenges or oppositions have been recorded.
5. Can the patent claims be easily infringed?
The scope depends on the specificity of the claims; broad claims covering general compounds can be more susceptible, whereas narrow claims impose higher barriers for infringement.
References
- European Patent Office. (2022). Patent DK2368890 public file. Retrieved from https://patentinfo.eu/dk2368890/
